problem associated with this is that most patients are not in balance at any one time. To overcome this one The nutritional assessment of patients with chronic needs to undertake nitrogen balance whereby patients renal failure includes an assessment of body fat, fat are admitted to a metabolic ward and placed either on free mass (subdivided into somatic and visceral protein) a diet with the same caloric and nitrogen content as [1] and dietary intake. Figure 1 shows some of the their usual diet (isocaloric, isonitrogenous) or an methods that can be used to assess fat free mass and experimental diet if this the aim of the study [4, 5] . All dietary intake. A few are applicable to everyday clinical urine and faeces are collected and the nitrogen content practice whereas others should be seen only as research (U N and F N ) measured directly. The nitrogen intake tools. Methods of dietary assessment include precise (I N ) is calculated by the direct measurement of nitrogen weighing, a weighed inventory, a dietary history and in an aliquot from a homogenate of a parallel total dietary recall [2, 3] . In clinical practice a 3 day dietary daily dietary intake. In CRF it is necessary to take history is commonly used but lacks the accuracy necesinto account any changes that may occur in the body sary for clinical research. Most such studies use a urea nitrogen pool (BUN×V d ) during the period of weighed inventory. However, with increasing complexassessment with daily measurements of BUN. Using ity of dietary assessment there is a danger that patients linear regression the change in the pool (D N ) can then will change their normal dietary practice to facilitate be estimated and used to calculate nitrogen balance the assessment. Another method that is commonly (B N ) where: used is to measure the urea production rate and then using a variety of regression equations derived from B N =I N −U N −F N −D N other studies to estimate total nitrogen output. It is To undertake accurate nitrogen balance studies then assumed that the patient is in neutral nitrogen requires meticulous attention to detail [6 ] . It is not a balance (i.e. what is going in equals what is coming tool that can be used in routine clinical practice and out) and the dietary protein intake is therefore the there are now only a few clinical research centres world product of the total nitrogen output and 6.25 (assuming wide capable of undertaking it. If the aim of the study is to assess the effect of a dietary intervention it is necessary to allow a period of equilibration of up to one week before starting to measure nitrogen balance.
The concept of protein turnover
Nitrogen balance ignores the fact that there is a turnover of protein within the body which is approximately five times greater than the daily protein intake [7] . For example, protein turnover in an individual consuming a 60 g protein diet is of the order of 300 g per day. It is the daily balance between whole body protein degradation (PD) and whole body protein synthesis (PS) that dictates whether an individual is in neutral nitrogen balance, positive nitrogen balance (anabolic) or negative nitrogen balance (catabolic). ure both whole body and specific tissue protein turn- over. It was Rudolf Schoenheimer who in 1939 first the equation for flux becomes described the use of leucine isotopes in the study of Q=B+I=S+C protein metabolism in vivo in humans [8] . To undertake such studies requires a model of protein metabolism The most frequently used amino acid is leucine, a branched chain amino acid with only one pathway of which can be used to calculate PD and PS. In the model shown in Figure 2 the flux of an amino acid (Q) catabolism. It is predominantly metabolized in muscle and provides by transamination an intracellular marker is equivalent to dietary intake (I) plus the input from protein breakdown (B) and the input from de novo of leucine carbon, a-ketoisocaproic acid (a-KIC ).
Measurement of protein turnover
Human experiments now usually use leucine labelled synthesis (N ). Flux is also equivalent to incorporation of amino acid into body protein (S ), plus oxidation at the 1 carbon position with 13C. expired air using isotope ratio mass spectrometry (i) A steady state is present.
(ii) The dose of tracer will not have any effect on (IRMS ). -[1-13C ]leucine is usually administered as a primed constant intravenous infusion; a priming dose metabolism of tracee (i.e. is a true tracer). This may particularly be a problem with the flooding of NaH13CO 3 is also given and this enables isotopic equilibrium to be reached in as short a time as possible. dose method [12] whereby a large bolus of (3-4 g) of labelled and unlabelled amino acid is give to Typically a 4-5 h infusion will be undertaken. Samples of expired air and plasma are taken before the start of rapidly flood all the free amino acid pools to a common value which can be determined by the infusion and at 15 min intervals during the last hour of the study. The plasma samples are derivatized sampling the plasma pool. (iii) The labelled and unlabelled amino acids are to a product of KIC which can be analysed for 13C enrichment by gas chromatography mass spectrometry.
handled are studied both fasting and fed then it is possible to calculate a balance between leucine disappearance into body protein (S ) and leucine appearance from body protein (B) in both states. This leucine balance can be References converted to a nitrogen equivalent, assuming that body protein contains (by weight) 8% leucine and 16%
